Toxicology Study Design for Peptide-Oligonucleotide Conjugate Therapeutics: A CRO Perspective
Introduction: The convergence of peptide chemistry and oligonucleotide biology has produced one of the most promising — and analytically demanding […]
How to Select Materials for Low-Leachables Packaging Systems
Introduction Selecting Low-Leachables Packaging Materials for critical pharmaceutical and biopharmaceutical systems requires a structured, science-driven assessment of polymer thermodynamics, migration
How to Select Materials for Low-Leachables Packaging Systems Read More »
Why Do Some Biosimilars Fail Regulatory Approval? The Most Common Development Pitfalls
Understanding Why Biosimilars Fail Regulatory Approval: An Analytical Overview Biosimilars fail regulatory approval primarily because of deficiencies in chemistry, manufacturing,
Why Do Some Biosimilars Fail Regulatory Approval? The Most Common Development Pitfalls Read More »
What Analytical Tests Are Mandatory for a Biosimilar Regulatory Submission?
Introduction: Understanding which analytical tests for biosimilar regulatory submission are mandatory is one of the most complex challenges in biologic drug development.
What Analytical Tests Are Mandatory for a Biosimilar Regulatory Submission? Read More »
Mass Spectrometry Characterization of Peptide-Oligonucleotide Conjugates: Techniques and Data Interpretation
Introduction to Mass Spectrometry Characterization of Peptide-Oligonucleotide Conjugates Mass spectrometry characterization of peptide-oligonucleotide conjugates is a sophisticated, multi-dimensional analytical approach
LC-MS/MS Services for Biosimilar Comparability Studies
Introduction to Advanced Biosimilar Comparability Demonstrating analytical similarity is the cornerstone of biosimilar development, serving as the primary step in
LC-MS/MS Services for Biosimilar Comparability Studies Read More »
Biosimilar Aggregation and Particle Analysis Service: SEC-MALS, DLS, and MFI Explained
Introduction Biosimilar Aggregation Analysis sits at the center of every biosimilar comparability program, because protein aggregates — whether a few
Biosimilar Aggregation and Particle Analysis Service: SEC-MALS, DLS, and MFI Explained Read More »
Future Trends in Generic Injectable Drug Development
Global Market Dynamics and Generic Injectable Trends The global market for sterile injectables is undergoing a significant transformation, rapidly shifting
Future Trends in Generic Injectable Drug Development Read More »
Case Study: Disulfide Bond Mapping and Structural Confirmation of a Cyclic Peptide Drug for ANDA
Introduction: Disulfide Bond Mapping of Cyclic Peptides is one of the most technically demanding — and most heavily scrutinized —
Biosimilar Formulation Development Service: Stability, Excipient Screening, and Shelf-Life Studies
Advanced Optimization in Biosimilar Formulation Development Service Stability A comprehensive biosimilar formulation development service stability program is designed to ensure